Find compound explainers, evidence reviews, comparisons, product-specific preparation guidance and practical research tools. Use the protocol directory to start with a vial.
Source-linked mechanism library · 71 topics
Mechanism explainedIGF-1 LR3 is an engineered IGF-1 analogue designed to bind IGF-binding proteins less strongly than native IGF-1. Its evidence base is chiefly structural, cell-culture and animal research…
Read the research
Mechanism explainedBPC-157 is a synthetic 15-amino-acid peptide promoted for tissue repair, but the strongest direct evidence remains in cell systems and rodent injury models. Small human reports exist, yet…
Read the research
Mechanism explainedEvidence-grounded Australian educational material distinguishing the registered tirzepatide medicine from unregulated products, with primary clinical-trial results, safety context, and…
Read the research
Mechanism explainedRetatrutide is a purpose-designed peptide that activates GIP, GLP-1 and glucagon receptors. Randomised phase 2 trials have reported substantial short-term improvements in body weight and…
Read the research
Mechanism explainedTrace the hormone from hypothalamus to oxytocin receptor, then see why proven obstetric uses cannot be stretched into a promise about bonding or mood.
Read the research
Mechanism explainedThree missing amino acids change an experimental protein interaction. Follow the receptor pathway without turning cell and rat results into a human muscle-growth claim.
Read the researchShowing 71 articles
Mechanism explained5-Amino-1MQ is often grouped with “peptides” online, but its chemistry and evidence say otherwise: it is a small-molecule NNMT inhibitor. Its most direct evidence is biochemical and…
Mechanism explainedAdamax is marketed as a Semax-related synthetic peptide, but it has no verified, standardised public research identity and no located human evidence. Commercial catalogues disagree over its…
Mechanism explainedAdipotide is unusual among proposed weight-loss compounds because its intended target is the blood-vessel network supporting white adipose tissue, rather than a gut-hormone receptor or…
Mechanism explainedAICAR/acadesine is a nucleoside analogue often described as an AMPK activator, but that shorthand is incomplete. In a controlled study of 29 healthy men, it increased skeletal-muscle tracer…
Mechanism explainedAOD-9604 is a modified fragment of growth hormone, not full-length HGH. Early mouse experiments examined body-weight and fat-metabolism measures, but those model-specific findings do not…
Mechanism explainedARA-290 is a short EPO-derived peptide developed to engage a tissue-protection signalling concept without EPO’s red-blood-cell-stimulating activity. Rodent nerve-injury findings and several…
Mechanism explainedBPC-157 is a synthetic 15-amino-acid peptide promoted for tissue repair, but the strongest direct evidence remains in cell systems and rodent injury models. Small human reports exist, yet…
Mechanism explainedCagrilintide is a long-acting amylin analogue being studied for obesity and type 2 diabetes, alone and in the fixed combination CagriSema with semaglutide. It has credible randomised human…
Mechanism explainedCardiogen is the name commonly used for the synthetic four-amino-acid peptide AEDR. The evidence located is experimental rather than clinical: one rat myocardial explant study reported…
Mechanism explainedCartalax is the three-amino-acid peptide AED. Its strongest directly relevant finding is a single published in-vitro experiment in primary chondrocytes from young and old rats, in which 200…
Mechanism explainedCerebrolysin is a porcine-brain-derived peptide-and-amino-acid mixture, not a single ‘brain peptide’. It has been studied in stroke, dementia and traumatic brain injury, but its strongest…
Mechanism explainedChonluten is EDG, a three-amino-acid peptide promoted as a ‘bronchial’ bioregulator. Its directly relevant published evidence is laboratory-level: a 2022 study used synthetic EDG in a human…
Mechanism explainedCJC-1295 no-DAC is a synthetic GHRH-fragment analogue, usually called modified GRF (1-29). Its name is frequently conflated with CJC-1295, but the landmark CJC-1295 studies used an added…
Mechanism explainedCJC-1295 with DAC is an albumin-binding synthetic GHRH analogue, not growth hormone itself. Small controlled studies in healthy adults measured sustained increases in GH and IGF-I, but they…
Mechanism explainedCortagen is the defined four-amino-acid peptide AEDP, not an approved Australian medicine or a validated ‘brain injection’ protocol. The directly checked literature reports rat…
Mechanism explainedCrystagen is best treated as an investigational short-peptide topic rather than an established immune medicine. Its defined research identity is EDP (Glu-Asp-Pro), but products sold under…
Mechanism explainedDelta sleep-inducing peptide (DSIP) is a nine-amino-acid peptide first characterised in rabbit experiments, not an established treatment for insomnia, stroke, growth-hormone deficiency or…
Mechanism explainedEpithalon, more commonly indexed as epitalon, is the defined four-amino-acid peptide AEDG. Its most discussed laboratory finding is an association with telomerase-related signals and longer…
Mechanism explainedFOXO4-DRI is a laboratory-engineered peptide being studied as a way to make some senescent cells undergo apoptosis. Its molecular interaction with p53 has been measured, and experiments…
Mechanism explainedGHK-Cu has biologically interesting, model-specific findings in fibroblast culture, rat wound chambers and a mouse scald model, plus an older placebo-controlled topical diabetic-ulcer…
Mechanism explainedGHRP-2 is a synthetic ghrelin-receptor agonist that can provoke growth-hormone secretion. It has a defined diagnostic role in a Japanese product, while small human studies and animal…
Mechanism explainedGHRP-6 is a real synthetic peptide with reproducible acute GH-secretagogue activity in controlled research. That narrow finding is not evidence that self-administered products improve…
Mechanism explained‘Glow stack’ is a marketing description, not a medicine name or molecular identity. Its usual proposed components have different research histories, formulations and evidence levels: GHK-Cu…
Mechanism explainedGlutathione is a genuine tripeptide made within cells and central to redox chemistry. Human oral studies show inconsistent changes in blood and cellular glutathione-related biomarkers…
